1,234
Views
21
CrossRef citations to date
0
Altmetric
Research Paper

Dynamic changes of different phenotypic and genetic circulating tumor cells as a biomarker for evaluating the prognosis of RCC

, , , , , , , , , & show all
Pages 505-512 | Received 30 May 2018, Accepted 15 Oct 2018, Published online: 25 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yasi Xing, Xinfa Zhang, Fangyuan Qin, Jingwen Yang, Lei Ai, Qingsong Wang & Yaping Zhai. (2022) The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients. Bioengineered 13:2, pages 2128-2136.
Read now

Articles from other publishers (20)

Ilenia Mastrolia, Virginia Catani, Marco Oltrecolli, Stefania Pipitone, Maria Giuseppa Vitale, Valentina Masciale, Chiara Chiavelli, Carlo Augusto Bortolotti, Cecilia Nasso, Giulia Grisendi, Roberto Sabbatini & Massimo Dominici. (2023) Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers. Biology 12:6, pages 877.
Crossref
Tito Palmela Leitão, Patrícia Corredeira, Sandra Kucharczak, Margarida Rodrigues, Paulina Piairo, Carolina Rodrigues, Patrícia Alves, Ana Martins Cavaco, Miguel Miranda, Marília Antunes, João Ferreira, José Palma Reis, Tomé Lopes, Lorena Diéguez & Luís Costa. (2023) Clinical Validation of a Size-Based Microfluidic Device for Circulating Tumor Cell Isolation and Analysis in Renal Cell Carcinoma. International Journal of Molecular Sciences 24:9, pages 8404.
Crossref
Mingyang Li, Lei Li, Jianyi Zheng, Zeyu Li, Shijie Li, Kefeng Wang & Xiaonan Chen. (2023) Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application. Molecular Cancer 22:1.
Crossref
Anabela Couto-Cunha, Carmen Jerónimo & Rui Henrique. (2022) Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?. Cancers 15:1, pages 287.
Crossref
Bo‐Han Chen, Chien‐Chang Kao, Ting Xu, Yung‐Ning Yang, Tai‐Lung Cha, Yi‐Ta Tsai, Shu‐Yu Liu, Sheng‐Tang Wu, En Meng, Chih‐Wei Tsao, Chin‐Li Chen, Guang‐Huan Sun, Dah‐Shyong Yu, Sun‐Yran Chang & Ming‐Hsin Yang. (2022) Determining programmed cell death ligand 1 expression in circulating tumor cells of patients with clear cell renal cell carcinoma and its correlation with response to programmed cell death protein 1 inhibitors. International Journal of Urology 29:9, pages 947-954.
Crossref
Deyu Li, Na Li & Ying Ding. (2022) Epithelial‑to‑mesenchymal transition of circulating tumor cells and CD133 expression on predicting prognosis of thyroid cancer patients. Molecular and Clinical Oncology 17:3.
Crossref
Kelly Ascenção & Csaba Szabo. (2022) Emerging roles of cystathionine β-synthase in various forms of cancer. Redox Biology 53, pages 102331.
Crossref
Yibing Guan, Fangshi Xu, Juanhua Tian, Yiyuan Wang, Ni Guo, Ziyan Wan, Minxin He, Mei Gao, Ke Gao & Tie Chong. (2022) Prognostic value of circulating tumor cells and immune-inflammatory cells in patients with renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations 40:4, pages 167.e21-167.e32.
Crossref
Xun Weng, YangYang & Yujiao Cai. (2022) Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients. Disease Markers 2022, pages 1-8.
Crossref
Joanna Bialek, Andreas Wencker, Felix Kawan, Stefan Yankulov, Paolo Fornara & Gerit Theil. (2022) Potential Use of CTCs as Biomarkers in Renal Cancer Patients. Life 12:1, pages 89.
Crossref
Jinbo Song, Zhe Yu, Bingqi Dong, Mingkai Zhu, Xiaofeng Guo, Yongkang Ma, Shiming Zhao & Tiejun Yang. (2021) Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma. World Journal of Surgical Oncology 19:1.
Crossref
Yibing Guan, Fangshi Xu, Juanhua Tian, Ke Gao, Ziyan Wan, Yiyuan Wang, Mei Gao, Zhenlong Wang & Tie Chong. (2021) The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma. BMC Cancer 21:1.
Crossref
Pei-Jhang Chiang, Ting Xu, Tai-Lung Cha, Yi-Ta Tsai, Shu-Yu Liu, Sheng-Tang Wu, En Meng, Chih-Wei Tsao, Chien-Chang Kao, Chin-Li Chen, Guang-Huan Sun, Dah-Shyong Yu, Sun-Yran Chang & Ming-Hsin Yang. (2021) Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma. Biology 10:7, pages 674.
Crossref
Michele Marchioni, Juan Gomez Rivas, Anamaria Autran, Moises Socarras, Simone Albisinni, Matteo Ferro, Luigi Schips, Roberto Mario Scarpa, Rocco Papalia & Francesco Esperto. (2021) Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art. Current Urology Reports 22:6.
Crossref
Tito Palmela Leitão, Miguel Miranda, Joana Polido, João Morais, Patrícia Corredeira, Patrícia Alves, Tiago Oliveira, Ricardo Pereira e Silva, Ricardo Fernandes, João Ferreira, José Palma Reis, Tomé Lopes & Luís Costa. (2021) Circulating tumor cell detection methods in renal cell carcinoma: A systematic review. Critical Reviews in Oncology/Hematology 161, pages 103331.
Crossref
Francesco Claps & M. Carmen Mir. (2021) Novel Expanding Renal Cell Carcinoma Biomarkers. Société Internationale d’Urologie Journal 2:1, pages 32-42.
Crossref
Jamal Majidpoor & Keywan Mortezaee. (2021) Steps in metastasis: an updated review. Medical Oncology 38:1.
Crossref
Yun‐Fan Sun, Peng‐Xiang Wang, Jian‐Wen Cheng, Zi‐Jun Gong, Ao Huang, Kai‐Qian Zhou, Bo Hu, Ping‐Ting Gao, Ya Cao, Shuang‐Jian Qiu, Jian Zhou, Jia Fan, Wei Guo & Xin‐Rong Yang. (2020) Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection. Cancer Cytopathology 128:10, pages 733-745.
Crossref
Nobuhiro Haga, Akifumi Onagi, Tomoyuki Koguchi, Seiji Hoshi, Soichiro Ogawa, Hidenori Akaihata, Junya Hata, Hiroyuki Hiraki, Ruriko Honda, Ryo Tanji, Kanako Matsuoka, Masao Kataoka, Yuichi Sato, Kei Ishibashi & Yoshiyuki Kojima. (2019) Perioperative Detection of Circulating Tumor Cells in Radical or Partial Nephrectomy for Renal Cell Carcinoma. Annals of Surgical Oncology 27:4, pages 1272-1281.
Crossref
Shengming Wu, Lei Gu, Jingwen Qin, Lei Zhang, Fenyong Sun, Zhongchen Liu, Yilong Wang & Donglu Shi. (2020) Rapid Label-Free Isolation of Circulating Tumor Cells from Patients’ Peripheral Blood Using Electrically Charged Fe 3 O 4 Nanoparticles . ACS Applied Materials & Interfaces 12:4, pages 4193-4203.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.